Mumbai, February 4, 2025 – Kilitch Drugs (India) Ltd. (BSE: 524500 | NSE: KILITCH) has announced the appointment of its Wholetime Director, Mr. Bhavin Mukund Mehta, as the Vice-Chairman of the Pharmaceuticals Export Promotion Council of India (Pharmexcil).
Industry Leadership & Experience
Mr. Bhavin Mehta brings over 25 years of experience in the pharmaceutical industry, having played a key role in Kilitch Drugs' expansion into global markets. His expertise spans business development, strategy management, international marketing, and operations.He has been actively involved in Pharmexcil since 2012 when he was appointed Chairman of the Exhibition Committee, contributing to the launch of IPHEX, India's largest pharmaceutical exports exhibition.
Official Statement
Commenting on his appointment, Mr. Bhavin Mehta stated:About Pharmexcil
Established by the Ministry of Commerce & Industry, Pharmexcil facilitates market insights, regulatory support, and participation in international trade fairs, assisting Indian pharmaceutical companies in expanding their export footprint.Since its inception in 2004, Pharmexcil has played a pivotal role in making India a leading exporter of generic medicines.
About Kilitch Drugs (India) Ltd.
Founded in 1978, Kilitch Drugs (India) Ltd. is a leading pharmaceutical manufacturer with operations in Mumbai, Ethiopia, and an upcoming facility in Pen, Maharashtra. The company specializes in injectables, ophthalmic, OSD, and nutraceuticals, targeting global markets, including USFDA compliance.Kilitch’s facilities are certified by WHO GMP, ISO 9001, ISO 13485, and various international regulatory bodies in Kenya, Nigeria, Ghana, Sudan, the Philippines, and Ethiopia, ensuring compliance with global pharmaceutical standards.